Загрузка...
Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery
OBJECTIVE: Stereotactic radiosurgery (SRS) is routinely used to treat brain metastases from melanoma due to their radioresistant nature. The median survival for these patients is 4–6 months, according to earlier studies. The aim of this study was to evaluate prognostic factors that influence surviva...
Сохранить в:
| Опубликовано в: : | J Neurosurg |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7469983/ https://ncbi.nlm.nih.gov/pubmed/27903181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2016.8.GKS161359 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|